Charlotte Hanneman to succeed Abhijit Bhattacharya as Philips’
Chief Financial Officer (CFO)
February 28, 2024
Proposal to appoint Ms. Hanneman as member of Philips’ Board of
Management fulfilling the role of CFO per October 1, 2024
Amsterdam, the Netherlands – Royal
Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, today announced the proposal to appoint Charlotte
Hanneman as member of the Board of Management, fulfilling the role
of Chief Financial Officer (CFO), effective October 1, 2024. The
proposal will be submitted to the Annual General Meeting of
Shareholders (AGM), to be held on May 7, 2024.
Ms. Hanneman will join Philips as a member of Philips’ Executive
Committee on June 1, 2024, to start her induction and transition
into the role, succeeding current CFO Abhijit Bhattacharya on
October 1, 2024. Mr. Bhattacharya has been CFO and member of
Philips’ Board of Management and Executive Committee since 2015 and
will retire from the company after a successful 37-year career on
September 30, 2024.
Ms. Hanneman (Dutch, 1978) will join Philips with over 20 years’
experience in the MedTech and pharmaceutical industries, most
recently as Controller and Head of Financial Planning &
Analysis at global medical technology company Stryker. In this
current role, she is responsible for financial control, enterprise
financial planning and analysis, and business development finance.
She is also responsible for indirect procurement, and directly
responsible for the finance teams across Europe, Middle East and
Africa, Canada, and Latin America.
Prior to this, she held several international finance leadership
roles at Stryker, and other multinational healthcare companies,
including Merck, Schering-Plough and Organon. Ms. Hanneman has
extensive experience working in the US and has lived in various
countries across Asia and Europe. She holds a master’s degree in
economics and an executive master of finance and control from
Maastricht University, the Netherlands.
Roy Jakobs, CEO of Royal Philips said: “I would like to thank
Abhijit for his significant contribution to the transformation of
Philips into a health technology company. His dedication and
leadership have made a major impact throughout his long 37-year
career in the company. In the future, I will miss him for his
character and the insight he brought to the boardroom, however, he
will remain our CFO until the end of September, ensuring a smooth
transition. On behalf of Philips’ Executive Committee, I wish him
all the best in his future endeavors.”
“This is an exciting time for Charlotte to join Philips. Her
strong MedTech and pharma knowledge spanning Europe, Asia, and the
US, as well as her extensive finance experience, coupled with her
energy and passion for the healthcare industry, make her an ideal
fit for the role.”
Charlotte Hanneman, incoming CFO of Royal Philips, added:
“Philips is on an exciting journey to create value with sustainable
impact. With its global reach, market leadership positions, and
patient- and people-focused innovation, Philips is well positioned
to help deliver real change across healthcare. I am looking forward
to joining the team to drive impact and continue to deliver on the
plans and commitments set for the future.”
Feike Sijbesma, Chairman of Philips’ Supervisory Board, said:
“On behalf of the Supervisory Board, I would like to thank Abhijit
for all he has done for Philips over a long and illustrious career
with the company and wish him the very best for the future. In
welcoming Charlotte, we are broadening the diversity of the Board
of Management while further deepening the industry expertise of the
team to help drive the plan to create value with sustainable
impact.”
Abhijit Bhattacharya, CFO of Royal Philips commented: “After
serving Philips and leading great teams for many years, helping to
shape the future of the company, the time is right for me to retire
from the company in September. I am fully focused on delivering on
Philips’ plan in the next six months and ensuring a seamless
handover to Charlotte.”
Additional information on Philips’ Board of Management and
Executive Committee can be found here.
For further information, please
contact:
Philips External RelationsSteve KlinkTel.: +31 6 1088
8824E-mail: steve.klink@philips.com
Philips Investor RelationsLeandro MazzoniTel.: +31 20
5977055E-mail: leandro.mazzoni@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people’s health and well-being through meaningful
innovation. Philips’ patient- and people-centric innovation
leverages advanced technology and deep clinical and consumer
insights to deliver personal health solutions for consumers and
professional health solutions for healthcare providers and their
patients in the hospital and the home. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
ultrasound, image-guided therapy, monitoring and enterprise
informatics, as well as in personal health. Philips generated 2023
sales of EUR 18.2 billion and employs approximately 69,700
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
Forward-looking statementsThis release contains
certain forward-looking statements with respect to the financial
condition, results of operations and business of Philips and
certain of the plans and objectives of Philips with respect to
these items. Examples of forward-looking statements include
statements made about the strategy, estimates of sales growth,
future EBITA, future developments in Philips’ organic business and
the completion of acquisitions and divestments. By their nature,
these statements involve risk and uncertainty because they relate
to future events and circumstances and there are many factors that
could cause actual results and developments to differ materially
from those expressed or implied by these statements.
This press release contains inside information within the
meaning of Article 7(1) of the EU Market Abuse Regulation.
- Charlotte Hanneman
- Abhijit Bhattacharya
Koninklijke Philips NV (TG:PHI1)
Historical Stock Chart
From Oct 2024 to Nov 2024
Koninklijke Philips NV (TG:PHI1)
Historical Stock Chart
From Nov 2023 to Nov 2024
